These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 1697824
1. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration. Psuja P, Lewandowski K, Turowiecka Z, Zozulińska M, Tokarz A, Zawilska K. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824 [Abstract] [Full Text] [Related]
2. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation. Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD. Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357 [Abstract] [Full Text] [Related]
3. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors. Saito M, Nakabayashi T, Iuchi K, Ishikawa T, Kaseno K, Yoshida T, Asakura H, Matsuda T. Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363 [Abstract] [Full Text] [Related]
4. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation. Kaneko J, Sugawara Y, Tamura S, Togashi J, Matsui Y, Akamatsu N, Kishi Y, Makuuchi M. Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329 [Abstract] [Full Text] [Related]
5. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction. Gram J. Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835 [Abstract] [Full Text] [Related]
6. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y. J Cardiol; 1993 Jun; 23(4):335-41. PubMed ID: 8064582 [Abstract] [Full Text] [Related]
7. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic. Topper MJ, Prasse KW. Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506 [Abstract] [Full Text] [Related]
15. [Molecular marker for detecting hypercoagulable state]. Magari Y, Mizunaga S, Ito M, Shibata T, Ito H. Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279 [Abstract] [Full Text] [Related]
16. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
17. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency. Herren T, Straub PW, Haeberli A. Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646 [Abstract] [Full Text] [Related]
19. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]. Dittel M, Haushofer A, Spiel R, Halbmayer WM, Prachar H, Fischer M, Mlczoch J. Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710 [Abstract] [Full Text] [Related]